The high tariffs imposed by the US on Indian goods could be a major risk to India’s growth, according to a recent report by Crisil Intelligence.
Category: trade
The tariff blitz continues. Donald Trump has now imposed a 100 per cent duty on pharmaceutical drugs from October 1. This could hurt Indias drug makers, as America is one of their largest markets, earning $8. 7 billion from pharma exports to the US in 2024 alone.
Commerce and Industry Minister Piyush Goyal said that the two countries have reset their targets and are actively working to increase investments rapidly in different sectors and enhance collaborations in areas such as renewable energy, shipbuilding, retail, and pharmaceuticals.